Literature DB >> 7191812

Preparation and biological properties of a covalent antitumor drug--arm---carrier (DAC conjugate).

M Monsigny, C Kieda, A C Roche, F Delmotte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7191812     DOI： 10.1016/0014-5793(80)81026-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  5 in total

1.  Muramyl dipeptide bound to poly-L-lysine substituted with mannose and gluconoyl residues as macrophage activators.

Authors:  D Derrien; P Midoux; C Petit; E Nègre; R Mayer; M Monsigny; A C Roche
Journal:  Glycoconj J       Date:  1989       Impact factor: 2.916

2.  A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies.

Authors:  A Trouet; M Masquelier; R Baurain; D Deprez-De Campeneere
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

3.  Biodistribution and tumour localisation of a daunomycin-monoclonal antibody conjugate in nude mice with human tumour xenografts.

Authors:  M V Pimm; M A Paul; Y Ogumuyiwa; R W Baldwin
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

4.  Growth inhibition of the intestinal parasite Giardia lamblia by a dietary lectin is associated with arrest of the cell cycle.

Authors:  E Ortega-Barria; H D Ward; G T Keusch; M E Pereira
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

5.  Comparison of the liver subcellular distribution of free daunomycin and that bound to galactosamine targeted N-(2-hydroxypropyl)methacrylamide copolymers, following intravenous administration in the rat.

Authors:  S R Wedge; R Duncan; P Kopeckova
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.